Skip to main content
Caplight Logo









Cypre Inc.

Cypre Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.cypre.com/

Last Round

Seed Round

Jan 10, 2024

Total Funding Raised

$1.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cypre Inc. is a biotechnology company that develops a 3D tumor modeling platform designed to improve the process of cancer drug development and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

3D tumor modelsorganoid platformoncology drug discoverypreclinical researchhydrogel technologytumor microenvironmentTMEIND-enabling studieshigh-content imaginganimal-alternative modelsbiomarker discoveryin vitro testingdrug efficacyorgan-on-a-chip3D cell culture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cypre Inc. Comparables

Compare Cypre Inc. with similar companies based on industry and business-model similarity.

Cypre Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carcinotech
88%
ScreenIn3D
86%
Xilis
85%

Cypre Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJan 10, 2024
SeedAug 10, 2018
Convertible DebtJan 18, 2017

Cypre Inc. Investors

Notable investors and investment history

Cypre Inc. investors
InvestorRounds
Hemi VenturesSeed
Kluz VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 49% MoM.

  • May 12, 2026

    Monthly visitors grew 1891% MoM, from 79 to 1.6K.

Cypre Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cypre Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cypre Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2016
Last FundingJan 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?